查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1370952

基因组学市场中的区块链 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按业务模式、服务、按应用、最终用户、地区和竞争细分

Blockchain in Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Business Model, By Service, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 189 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2022 年全球区块链基因组市场价值为 10.6 亿美元，预计在预测期内将实现强劲增长，复合年增长率 (CAGR) 为 11.11%，预计到 2028 年将达到 19.8 亿美元。数位化公共分类帐将交易和资料记录为区块，提供了一个分散的网络，用于跨互连的资料库系统分发资料。它透过适当的授权实现全球访问，使用户能够控制资料分发以保护隐私。利用非对称加密技术透过加密增强资料安全性。出售或捐赠资料时，接收者会收到用于独占存取的私有解密金钥，从而防止未经授权的入侵。区块链促进基因组资料的储存、管理和交换。其去中心化模式有利于银行、金融、生物製药和基因组研究等产业。在这些产业中，区块链促进基因组资料提供者和客户之间的交易和支付，帮助决策。区块链平台促进资料提供者（用户）和买家（包括製药公司和研究机构）之间的直接互动。

主要市场驱动因素

私人投资者和创投家的投资不断增加

市场概况
预测期 2024-2028
2022 年市场规模 10.6亿美元
2028 年市场规模 19.8亿美元
2023-2028 年复合年增长率 11.11%
成长最快的细分市场 製药与生物技术公司
最大的市场 北美洲

增加投资使研究人员和创新者能够探索和开发专为基因组学量身定制的区块链解决方案。这笔资金支持利用区块链功能的新平台、工具和应用程式。私人参与者和创投家加速基因组学区块链解决方案的开发。这会带来更快的技术进步，使区块链更容易存取并适用于基因组研究和资料管理。资金支持创建强大且可扩展的区块链基础设施，以安全处理大量基因组资料。投资促进利害关係人之间的合作，包括研究人员、产业参与者、技术提供者和医疗机构。风险资本投资推动了专注于基因组学的新创公司开发区块链解决方案的成长。这些新创公司为新平台、工具和应用程式做出了贡献，增加了对区块链技术的需求。区块链投资简化了临床试验、资料共享和研究协作，提高了基因组学研究的效率。

基因组学的不断发展

区块链的去中心化和安全性可以保护基因组资料免于未经授权的存取和洩露，从而确保病患隐私。它使个人能够控制基因组资料的访问，授予或撤销与研究人员或医疗保健提供者共享的许可。区块链建立了安全平台，用于跨多个实体共享和存取基因组资料，同时保持资料完整性。随着时间的推移，不变性可确保资料的准确性和可靠性。

数位工具的采用不断增加

区块链技术中的数位工具增强了基因组资料的加密和安全性，确保机密性和保护。它们能够为基因组学研究中的个人创建和管理分散的身份，控制对个人基因组资料的存取。数位工具标准化了区块链上基因组资料的格式和元数据，促进资料检索和分析。它们可以在研究人员、医疗保健提供者和患者之间安全共享基因组资料，允许参与者定义存取权限并追踪资料使用情况。数位工具透过在区块链上记录资料杂凑或数位签章来验证基因组资料的完整性。它们可以即时追踪资料交易，提高透明度和可追溯性。

病患医疗服务数位化

区块链被认为是资料所有者和用户（例如研究团体和製药公司）之间值得信赖的交易方式。平台可以轻鬆存取基因组资料集，改善个人化药物和治疗研究的资讯采购。许多公司推广区块链来管理遗传资讯。製药企业和政府机构的策略合作伙伴关係以及风险资本投资表明，区块链平台用于遗传资料储存和管理的接受度越来越高。

主要市场挑战

监管挑战

由于基因组资料的独特性、资料隐私问题、资料所有权以及区块链的去中心化性质，出现了监管挑战。基因组资料的敏感性需要遵守资料隐私原则，这给获得区块链储存和使用的知情和明确同意带来了挑战。确定资料所有权并在去中心化区块链上主张权利非常复杂。适应或创建适应区块链特征的新法规至关重要。

缺乏资源和利害关係人

资源和熟练专业人员的稀缺可能会阻碍区块链解决方案的开发。需要金融投资、密码学和智能合约方面的技术专业知识以及强大的基础设施。缺乏资金可能会阻碍安全且可扩展的平台创建。为确保互通性和资料完整性，必须建立资料格式、术语和元资料标准。

主要市场趋势

技术创新

区块链创新可以增强资料安全、隐私功能和同意管理。这鼓励资料贡献和研究参与。创新平台可以建立安全的跨境资料共享和协作，加快研究步伐。不断发展的区块链技术和创新将推动其在基因组学中的采用。

推出新的基于区块链的平台

专用平台可以应对挑战并为资料共享、研究和个人化医疗创造环境。基因组学资料的客製化资料管理解决方案可以确保安全储存、共享和跟踪，增强资料完整性和隐私性。这些平台可以整合隐私功能和同意管理，鼓励资料贡献和参与。

细分市场洞察

商业模式见解

企业对客户 (B2C) 领域在 2020 年基因组学市场的全球区块链中占据主导地位。企业和中小企业采用 B2C 模式有助于收入成长。区块链为 B2C 公司提供安全的数位货币交易和独特的基因组资料处理。

应用洞察

资料共享和货币化领域预计将经历最高的收入成长率。区块链可以实现基因组资料的安全共享和货币化，从而加速研究和个人化医疗。

区域洞察

由于遗传性疾病盛行率上升、研发活动、区块链采用、政府对医疗保健研发的投资以及市场参与者的存在，北美在 2022 年引领全球基因组学市场的区块链。 GenoBank.io Inc.、LunaDNA、Longenesis Ltd. 和 Nebula Genomics, Inc. 等知名公司正在为区域市场的成长做出贡献。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：基因组学市场展望中的全球区块链

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依商业模式（B2B商业模式、B2C商业模式、C2B商业模式）
    • 按服务（实用代币和区块链平台）
    • 按应用（数据共享和货币化、数据存储和安全以及自动化健康保险）
    • 按最终用户（製药和生物技术公司、医院和医疗保健提供者、研究机构、数据所有者等）
    • 按地区
    • 按公司划分 (2022)
  • 市场地图

第 6 章：北美基因组学市场展望中的区块链

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按商业模式
    • 按服务
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲基因组学市场展望中的区块链

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按商业模式
    • 按服务
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 欧洲：国家分析
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙

第 8 章：亚太地区区块链在基因组学市场前景

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按商业模式
    • 按服务
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第 9 章：南美洲基因组学市场展望中的区块链

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按商业模式
    • 按服务
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲基因组学市场展望中的区块链

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 按商业模式
    • 按服务
    • 按应用
    • 按最终用户
    • 按国家/地区
  • MEA：国家分析
    • 南非基因组学区块链
    • 沙乌地阿拉伯基因组学区块链
    • 阿联酋区块链在基因体学的应用

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章：全球口腔临床营养市场：SWOT 分析

第 14 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第15章：竞争格局

  • 商业概览
  • 服务内容
  • 最近的发展
  • 主要人员
  • SWOT分析
    • Digital DNAtix Ltd.
    • Encrypgen Incorporated
    • Genobank.io Inc.
    • Genomes.io
    • Longenesis
    • LunaDNA, LLC
    • Nebula Genomics, Inc.
    • Shivom Ventures Limited
    • SimplyVital Health, Inc.
    • WuXi Nextcode Genomics, Inc.

第 16 章：策略建议

第 17 章：关于我们与免责声明

简介目录
Product Code: 4660

The Global Blockchain in Genomics Market was valued at USD 1.06 Billion in 2022 and is projected to experience robust growth during the forecast period, with a Compound Annual Growth Rate (CAGR) of 11.11% and expected to reach USD 1.98 Billion through 2028. Blockchain, a digitized public ledger recording transactions and data as blocks, offers a decentralized network for distributing data across interconnected database systems. It enables global accessibility with proper authorization, providing users control over data distribution to safeguard privacy. Utilizing asymmetric cryptography enhances data security through encryption. When selling or donating data, recipients receive a private decryption key for exclusive access, preventing unauthorized intrusion. Blockchain facilitates the storage, management, and exchange of genomic data. Its decentralized model benefits sectors such as banking, finance, biopharmaceuticals, and genomic research. In these industries, blockchain facilitates transactions and payments between genomic data providers and customers, aiding decision-making. The blockchain platform fosters direct interaction between data providers (users) and buyers, including pharmaceutical firms and research institutes.

Key Market Drivers

Rising Investment by Private Players and Venture Capitalists

Market Overview
Forecast Period2024-2028
Market Size 2022USD 1.06 Billion
Market Size 2028USD 1.98 Billion
CAGR 2023-202811.11%
Fastest Growing SegmentPharmaceutical & Biotechnology Companies
Largest MarketNorth America

Increased investment empowers researchers and innovators to explore and develop blockchain solutions tailored for genomics. This funding supports new platforms, tools, and applications harnessing blockchain's capabilities. Private players and venture capitalists accelerate blockchain solution development for genomics. This leads to quicker technological advancements, making blockchain more accessible and applicable to genomic research and data management. Funding supports the creation of robust and scalable blockchain infrastructure for secure handling of large volumes of genomic data. Investments foster collaboration among stakeholders, including researchers, industry players, technology providers, and healthcare institutions. Venture capital investment drives growth in genomics-focused startups developing blockchain solutions. These startups contribute to new platforms, tools, and applications, increasing demand for blockchain technology. Blockchain investment streamlines clinical trials, data sharing, and research collaboration, enhancing efficiency in genomics research.

Increasing Developments in Genomics

Blockchain's decentralized and secure nature can protect genomic data from unauthorized access and breaches, ensuring patient privacy. It empowers individuals to control genomic data access, granting or revoking permission for sharing with researchers or healthcare providers. Blockchain establishes secure platforms for sharing and accessing genomic data across multiple entities while maintaining data integrity. Immutability ensures data accuracy and reliability over time.

Rising Adoption of Digital Tools

Digital tools in blockchain technology enhance encryption and security for genomic data, ensuring confidentiality and protection. They enable creation and management of decentralized identities for individuals in genomics research, controlling access to personal genomic data. Digital tools standardize formats and metadata for genomic data on the blockchain, facilitating data retrieval and analysis. They enable secure sharing of genomic data among researchers, healthcare providers, and patients, allowing participants to define access permissions and track data usage. Digital tools verify genomic data integrity by recording data hashes or digital signatures on the blockchain. They enable real-time tracking of data transactions, enhancing transparency and traceability.

Digitization of Healthcare Services by Patients

Blockchain is considered a trusted means of transactions between data owners and users, such as research groups and pharmaceutical companies. Platforms offer easy access to genomic datasets, improving information procurement for personalized drug and therapy research. Numerous companies promote blockchain for managing genetic information. Strategic partnerships involving pharmaceutical players and government bodies, along with venture capital investments, indicate growing acceptance of blockchain platforms for genetic data storage and management.

Key Market Challenges

Regulatory Challenges

Regulatory challenges arise due to the unique nature of genomic data, data privacy concerns, data ownership, and the decentralized nature of blockchain. Genomic data sensitivity requires adherence to data privacy principles, posing challenges in obtaining informed and explicit consent for blockchain storage and usage. Determining data ownership and asserting rights on a decentralized blockchain is complex. Adapting or creating new regulations accommodating blockchain's characteristics is crucial.

Lack of Resources and Stakeholders

Scarcity of resources and skilled professionals can hinder blockchain solution development. Financial investment, technical expertise in cryptography and smart contracts, and robust infrastructure are required. Lack of funding can impede secure and scalable platform creation. Established standards for data formats, terminologies, and metadata are necessary to ensure interoperability and data integrity.

Key Market Trends

Innovations in Technology

Blockchain innovations can enhance data security, privacy features, and consent management. This encourages data contribution and research participation. Innovative platforms can establish secure cross-border data sharing and collaboration, accelerating research pace. Evolving blockchain technology and innovations will drive its adoption in genomics.

Launch of New Blockchain-Based Platforms

Dedicated platforms can address challenges and create environments for data sharing, research, and personalized medicine. Customized data management solutions for genomics data can ensure secure storage, sharing, and tracking, enhancing data integrity and privacy. These platforms can integrate privacy features and consent management, encouraging data contribution and participation.

Segmental Insights

Business Model Insights

The Business to Customer (B2C) segment dominated the global blockchain in genomics market in 2020. Adoption of B2C models by enterprises and SMEs aids revenue growth. Blockchain facilitates secure digital currency transactions and unique genomic data processing for B2C companies.

Application Insights

The data sharing and monetization segment is expected to experience the highest revenue growth rate. Blockchain enables secure sharing and monetization of genomic data, accelerating research and personalized medicine.

Regional Insights

North America led the global blockchain in genomics market in 2022 due to rising genetic disorder prevalence, R&D activities, blockchain adoption, government investments in healthcare R&D, and presence of market players. Prominent companies, such as GenoBank.io Inc., LunaDNA, Longenesis Ltd., and Nebula Genomics, Inc., are contributing to regional market growth.

Key Market Players

  • Digital DNAtix Ltd.
  • Encrypgen Incorporated
  • Genobank.io Inc.
  • Genomes.io
  • Longenesis
  • LunaDNA, LLC
  • Nebula Genomics, Inc.
  • Shivom Ventures Limited
  • SimplyVital Health, Inc.
  • WuXi Nextcode Genomics, Inc.

Report Scope:

In this report, the Global Blockchain in Genomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below.

Blockchain in Genomics Market, By Business Model:

  • B2B Business Model
  • B2C Business Model
  • C2B Business Model

Blockchain in Genomics Market, By Service:

  • Utility Tokens
  • Blockchain Platforms

Blockchain in Genomics Market, By Application:

  • Data Sharing & Monetization
  • Data Storage & Security
  • Automated Health Insurance

Blockchain in Genomics Market, By End User:

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Healthcare Providers
  • Research Institutes
  • Data Owners
  • Others

Blockchain in Genomics Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Blockchain in Genomics Market.

Available Customizations:

  • Global Blockchain in Genomics market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blockchain in Genomics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Business Model (B2B Business Model, B2C Business Model, and C2B Business Model)
    • 5.2.2. By Service (Utility Tokens and Blockchain Platforms)
    • 5.2.3. By Application (Data Sharing & Monetization, Data Storage & Security, and Automated Health Insurance)
    • 5.2.4. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Healthcare Providers, Research Institutes, Data Owners, And Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2022)
  • 5.3. Market Map

6. North America Blockchain in Genomics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Business Model
    • 6.2.2. By Service
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Blockchain in Genomics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Business Model
        • 6.3.1.2.2. By Service
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Blockchain in Genomics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Business Model
        • 6.3.2.2.2. By Service
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Blockchain in Genomics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Business Model
        • 6.3.3.2.2. By Service
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Blockchain in Genomics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Business Model
    • 7.2.2. By Service
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Blockchain in Genomics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Business Model
        • 7.3.1.2.2. By Service
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. United Kingdom Blockchain in Genomics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Business Model
        • 7.3.2.2.2. By Service
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Italy Blockchain in Genomics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Business Model
        • 7.3.3.2.2. By Service
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. France Blockchain in Genomics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Business Model
        • 7.3.4.2.2. By Service
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Blockchain in Genomics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Business Model
        • 7.3.5.2.2. By Service
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia-Pacific Blockchain in Genomics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Business Model
    • 8.2.2. By Service
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Blockchain in Genomics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Business Model
        • 8.3.1.2.2. By Service
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Blockchain in Genomics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Business Model
        • 8.3.2.2.2. By Service
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Blockchain in Genomics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Business Model
        • 8.3.3.2.2. By Service
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Blockchain in Genomics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Business Model
        • 8.3.4.2.2. By Service
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Blockchain in Genomics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Business Model
        • 8.3.5.2.2. By Service
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. South America Blockchain in Genomics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Business Model
    • 9.2.2. By Service
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Blockchain in Genomics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Business Model
        • 9.3.1.2.2. By Service
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. Argentina Blockchain in Genomics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Business Model
        • 9.3.2.2.2. By Service
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Colombia Blockchain in Genomics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Business Model
        • 9.3.3.2.2. By Service
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. Middle East and Africa Blockchain in Genomics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Business Model
    • 10.2.2. By Service
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Blockchain in Genomics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Business Model
        • 10.3.1.2.2. By Service
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Saudi Arabia Blockchain in Genomics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Business Model
        • 10.3.2.2.2. By Service
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. UAE Blockchain in Genomics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Business Model
        • 10.3.3.2.2. By Service
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Oral Clinical Nutrition Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Digital DNAtix Ltd.
    • 15.5.2. Encrypgen Incorporated
    • 15.5.3. Genobank.io Inc.
    • 15.5.4. Genomes.io
    • 15.5.5. Longenesis
    • 15.5.6. LunaDNA, LLC
    • 15.5.7. Nebula Genomics, Inc.
    • 15.5.8. Shivom Ventures Limited
    • 15.5.9. SimplyVital Health, Inc.
    • 15.5.10. WuXi Nextcode Genomics, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer